Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer

BACKGROUND: We previously reported tumor mutation burden (TMB) as a potential prognostic factor for patients with advanced gastric cancer (AGC) receiving immunotherapy. We aimed to comprehensively understand the impact of tumor burden and TMB on efficacy and prognosis in immunotherapy-treated AGC pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xiao-Li, Xu, Jian-Ying, Wang, De-Shen, Chen, Dong-Liang, Ren, Chao, Li, Jia-Ning, Wang, Feng, Wang, Feng-Hua, Xu, Rui-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871293/
https://www.ncbi.nlm.nih.gov/pubmed/33613701
http://dx.doi.org/10.1177/1758835921988996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871293/
https://www.ncbi.nlm.nih.gov/pubmed/33613701
http://dx.doi.org/10.1177/1758835921988996

Ejemplares similares